Erdafitinib in Urothelial Carcinoma
N Engl J Med
.
2019 Oct 17;381(16):1594.
doi: 10.1056/NEJMc1911187.
Authors
Guru Sonpavde
1
,
Gottfrid Sjödahl
2
Affiliations
1
Dana-Farber Cancer Institute, Boston, MA gurup_sonpavde@dfci.harvard.edu.
2
Lund University, Lund, Sweden.
PMID:
31618552
DOI:
10.1056/NEJMc1911187
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Transitional Cell*
Humans
Protein Kinase Inhibitors
Urologic Neoplasms*
Substances
Protein Kinase Inhibitors